Global Recombinant Collagen Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Recombinant Collagen Market Insights, Forecast to 2034
Recombinant collagen, as a substitute for natural animal tissue collagen, has the potential to be widely used in fields such as biomaterials and biomedicine. A wide variety of recombinant collagen types and their derivatives can be industrialized on a certain scale in various expression systems.
Global Recombinant Collagen market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Recombinant Collagen industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Recombinant Collagen key manufacturers include Giant Biogene Holding, Avantor, ProColl, Merck, ACROBiosystems, Wuhan Fine Biotech, Shanxi Jinbo Bio-Pharmaceutical, Jiangsu Jland Biotech and Jiangsu Trautec Medical Technology, etc. Giant Biogene Holding, Avantor, ProColl are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Recombinant Collagen were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Recombinant Collagen market and estimated to attract more attentions from industry insiders and investors.
Recombinant Collagen can be divided into Recombinant Type I Collagen, Recombinant Type III Collagen and Recombinant Type XVII Collagen,, etc. Recombinant Type I Collagen is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Recombinant Collagen is widely used in various fields, such as Food Health Care, Beauty Cosmetics and Biomedical Materials,, etc. Food Health Care provides greatest supports to the Recombinant Collagen industry development. In 2022, global % sales of Recombinant Collagen went into Food Health Care filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Recombinant Collagen market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Recombinant Collagen market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Giant Biogene Holding
Avantor
ProColl
Merck
ACROBiosystems
Wuhan Fine Biotech
Shanxi Jinbo Bio-Pharmaceutical
Jiangsu Jland Biotech
Jiangsu Trautec Medical Technology
OriGene Technologies
Segment by Type
Recombinant Type I Collagen
Recombinant Type III Collagen
Recombinant Type XVII Collagen
Food Health Care
Beauty Cosmetics
Biomedical Materials
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Recombinant Collagen plant distribution, commercial date of Recombinant Collagen, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Recombinant Collagen introduction, etc. Recombinant Collagen Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Recombinant Collagen
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Recombinant Collagen market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Recombinant Collagen industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Recombinant Collagen key manufacturers include Giant Biogene Holding, Avantor, ProColl, Merck, ACROBiosystems, Wuhan Fine Biotech, Shanxi Jinbo Bio-Pharmaceutical, Jiangsu Jland Biotech and Jiangsu Trautec Medical Technology, etc. Giant Biogene Holding, Avantor, ProColl are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Recombinant Collagen were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Recombinant Collagen market and estimated to attract more attentions from industry insiders and investors.
Recombinant Collagen can be divided into Recombinant Type I Collagen, Recombinant Type III Collagen and Recombinant Type XVII Collagen,, etc. Recombinant Type I Collagen is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Recombinant Collagen is widely used in various fields, such as Food Health Care, Beauty Cosmetics and Biomedical Materials,, etc. Food Health Care provides greatest supports to the Recombinant Collagen industry development. In 2022, global % sales of Recombinant Collagen went into Food Health Care filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Recombinant Collagen market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Recombinant Collagen market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Giant Biogene Holding
Avantor
ProColl
Merck
ACROBiosystems
Wuhan Fine Biotech
Shanxi Jinbo Bio-Pharmaceutical
Jiangsu Jland Biotech
Jiangsu Trautec Medical Technology
OriGene Technologies
Segment by Type
Recombinant Type I Collagen
Recombinant Type III Collagen
Recombinant Type XVII Collagen
Segment by Application
Food Health Care
Beauty Cosmetics
Biomedical Materials
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Recombinant Collagen plant distribution, commercial date of Recombinant Collagen, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Recombinant Collagen introduction, etc. Recombinant Collagen Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Recombinant Collagen
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports